(Q37402218)

20 August 2017

1 reference

title

The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation (English)

1 reference

20 August 2017

0 references

Brian F McBride

1

1 reference

20 August 2017

language of work or name

1 reference

1 March 2009

1 reference

The Journal of Clinical Pharmacology

20 August 2017

published in

1 reference

20 August 2017

volume

49

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

258-267

1 reference

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

A comparison of rate control and rhythm control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Three-dimensional mapping of the common atrial flutter circuit in the right atrium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Structure and function of cardiac potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Modulation of the human Kv1.5 channel by protein kinase C activation: role of the Kvbeta1.2 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Human cardiac potassium channel DNA polymorphism modulates access to drug-binding site and causes drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Molecular determinants of HERG channel block.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

A structural basis for drug-induced long QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Distribution of the muscarinic K+ channel proteins Kir3.1 and Kir3.4 in the ventricle, atrium, and sinoatrial node of heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Atrial-selective approaches for the treatment of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Effect of atrial electrical remodeling on the efficacy of antiarrhythmic drugs: comparison of amiodarone with I(Kr)- and I(to)/IKur-blockade in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

A novel high-affinity inhibitor for inward-rectifier K+ channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

The bee venom peptide tertiapin underlines the role of I(KACh) in acetylcholine-induced atrioventricular blocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Inhibition by a novel anti-arrhythmic agent, NIP-142, of cloned human cardiac K+ channel Kv1.5 current

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Blockade by NIP-142, an antiarrhythmic agent, of carbachol-induced atrial action potential shortening and GIRK1/4 channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Vernakalant in the management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008325151

21 January 2018

Identifiers

DOI

10.1177/0091270008325151

1 reference

20 August 2017

1 reference